
doi: 10.1135/cccc20052053
N4-Substituted derivatives of HPMPC were synthesized in four-step synthesis which included treatment of 4-methoxypyrimidin-2(1H)-one (1) with (S)-[(trityloxy)methyl]oxirane in DMF. Condensation of intermediary 1-[2-hydroxy-3-(trityloxy)propyl]-4-methoxypyrimidin-2(1H)-one (2) with (diisopropoxyphosphoryl)methyl tosylate in the presence of sodium hydride resulted in fully protected 4-methoxypyrimidin-2(1H)-one derivative 3 which gave on reaction with an appropriate primary amine in dioxane N4-substituted products 4a-4i. The reaction with bromotrimethylsilane simultaneously cleaved the trityl group and deprotected the phosphonate residue and gave the title HPMP analogues substituted at the cytosine amino group in position N4 5a-5i. Compound 4j was prepared from 4-methoxypyrimidin-2(1H)-one (1) by reaction with cyclopropylamine in dioxane. The intermediary 4-(cyclopropylamino)pyrimidin-2(1H)-one (6) then reacts with (S)-[(trityloxy)methyl]oxirane in DMF. Fully protected phosphonate 4j and its deprotected counterpart 5j was obtained by the same sequence of reactions as in the case of compounds 5a-5i.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
